Data gathered: January 10
AI Stock Analysis - Tenaya Therapeutics (TNYA)
Analysis generated December 11, 2024. Powered by Chat GPT.
Tenaya Therapeutics is a biotechnology company specializing in the treatment of various cardiovascular diseases. The firm focuses on innovative gene therapies and drug discoveries to offer long-term solutions for heart conditions. Positioned at the forefront of biotechnology, Tenaya aims to leverage cutting-edge science and technology to develop therapies that can transform the landscape of cardiovascular treatment.
Stock Alerts - Tenaya Therapeutics (TNYA)
 |
Tenaya Therapeutics | January 8 Price is down by -5.4% in the last 24h. |
|
Tenaya Therapeutics | January 7 Price is up by 5.3% in the last 24h. |
|
Tenaya Therapeutics | January 3 Price is up by 5.6% in the last 24h. |
|
Tenaya Therapeutics | January 2 Price is up by 6.3% in the last 24h. |
Alternative Data for Tenaya Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 67 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 18 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,004 | Sign up | Sign up | Sign up |
| Instagram Followers | 96 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,214 | Sign up | Sign up | Sign up |
| Twitter Followers | 395 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 103 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 76 | Sign up | Sign up | Sign up |
| Linkedin Employees | 129 | Sign up | Sign up | Sign up |
About Tenaya Therapeutics
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
| Price | $1.42 |
| Target Price | Sign up |
| Volume | 2,510,000 |
| Market Cap | $112M |
| Year Range | $1.23 - $4.68 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
State Street Corp Acquires 9,506 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA)January 2 - ETF Daily News |
|
Short Interest in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Rises By 18.8%December 31 - ETF Daily News |
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart DiseaseDecember 29 - SeekingAlpha |
|
 |
Analyzing Caribou Biosciences (NASDAQ:CRBU) and Tenaya Therapeutics (NASDAQ:TNYA)December 25 - ETF Daily News |
|
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of “Buy” from BrokeragesDecember 23 - ETF Daily News |
|
XTX Topco Ltd Has $95,000 Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)December 22 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 8.5M | -8.5M | -26M | -25M | -0.300 |
| Q2 '24 | 0 | 10M | -10M | -29M | -29M | -0.340 |
| Q1 '24 | 0 | 11M | -11M | -32M | -32M | -0.400 |
| Q4 '23 | 18M | 11M | -11M | -30M | -29M | -0.400 |
| Q3 '23 | 0 | 10M | -10M | -29M | -29M | -0.390 |
Insider Transactions View All
| Saito Chihiro filed to sell 60,983 shares at $2.1. November 18 '24 |
| Saito Chihiro filed to sell 64,048 shares at $2.9. August 19 '24 |
| Saito Chihiro filed to sell 63,241 shares at $2.9. August 19 '24 |
| Saito Chihiro filed to sell 64,702 shares at $2.9. August 19 '24 |
| Ali Faraz filed to sell 188,331 shares at $2.9. August 16 '24 |
Similar companies
Read more about Tenaya Therapeutics (TNYA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tenaya Therapeutics?
The Market Cap of Tenaya Therapeutics is $112M.
What is the current stock price of Tenaya Therapeutics?
Currently, the price of one share of Tenaya Therapeutics stock is $1.42.
How can I analyze the TNYA stock price chart for investment decisions?
The TNYA stock price chart above provides a comprehensive visual representation of Tenaya Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tenaya Therapeutics shares. Our platform offers an up-to-date TNYA stock price chart, along with technical data analysis and alternative data insights.
Does TNYA offer dividends to its shareholders?
As of our latest update, Tenaya Therapeutics (TNYA) does not offer dividends to its shareholders. Investors interested in Tenaya Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tenaya Therapeutics?
Some of the similar stocks of Tenaya Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.